Clinical trial
Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular…
NCT00474864 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00474864 |
|---|---|
| Title | Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. |
| Official title | A Double-Blind, Placebo-Controlled, Parallel Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Healthy Subjects, Dyslipidaemias, Dyslipidaemia |
| Intervention type | Drug |
| Interventions | GW856553 |
| Enrollment | 66 |
| Start date | Jul 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | May 17, 2007 |
| Last update posted | Jun 6, 2012 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: